You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
8 July 2024
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
26 April 2022
APEIRON shareholders approve new group structure geared towards enabling innovation and growth
12 October 2021
APEIRON Biologics commences clinical COVID-19 trial with inhaled APN01
6 July 2021
APEIRON Biologics launches next clinical trial with innovative cancer therapy APN401
1 June 2021
APEIRON Biologics Announces Changes to Management and Supervisory Boards
19 May 2021
APEIRON Biologics’ APN01 selected for large-scale US trial in COVID-19